KASHAE ANDERSON: Open Payments
NPI 1588119622 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 19 payments from 11 companies in 2025. Trend: 2023 $330 · 2024 $356 · 2025 $372
Food & beverage: $347Education: $24
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| Biofrontera Inc. | 4 | $73 |
| Janssen Biotech, Inc. | 2 | $41 |
| UCB, Inc. | 2 | $30 |
| Almirall LLC | 1 | $29 |
| Amgen Inc. | 1 | $24 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $23 |
| Medtronic, Inc. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: SKYRIZI, TREMFYA, Bimzelx, Seysara, AMELUZ, OTEZLA, VALCHLOR, RINVOQ.
Industry payments across UT — which companies pay providers there.
